Ursodeoxycholic acid in complex treatment of patients with a metabolic syndrome

被引：0

作者：

Tanchenko, O. A. ^{[1
]}

Naryshkina, S. V. ^{[1
]}

机构：

[1] Amur State Med Acad, Blagoveshchensk, Russia

来源：

YAKUT MEDICAL JOURNAL | 2010年 / 04期

关键词：

metabolic syndrome; ursodeoxycholic acid; immunoreactive insulin; leptin; gamma-glutamyl transpeptidase; triglycerides;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Patients with metabolic syndrome who got ursodeoxycholic acid in complex treatment were examined. The indices of immunoreactive insulin, leptin were studied in dynamics with the use of immunoenzymatic method, the values of lipid spectrum, the data of ultrasound investigation of liver were determined. It was revealed that inclusion of ursodeoxycholic acid into the complex treatment of patients with metabolic syndrome lead to the decrease of indices of immunoreactive insulin, leptin, atherogenic fractions of lipids playing a leading role in the development and progressing of metabolic syndrome.

引用

下载

页码：38 / 40

页数：3

共 50 条

[21] CHOLESTASIS ASSOCIATED TO TURNERS-SYNDROME CAN BE REVERSED BY URSODEOXYCHOLIC ACID TREATMENT
LORIA, P
CALLEA, F
BOZZOLI, M
BAGNI, A
CONCARI, M
GUICCIARDI, ME
CARANI, C
MONTANINI, V
MANTOVANI, R
BERTOLOTTI, M
CARULLI, N
HEPATOLOGY, 1995, 22 (04) : 1369 - 1369
[22] Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid
Nisha, Yadav
Bobby, Zachariah
Wadwekar, Vaibhav
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 60 : 57 - 60
[23] Carnosic acid could be a new treatment option for patients with NAFLD or the metabolic syndrome
Claire Greenhill
Nature Reviews Gastroenterology & Hepatology, 2011, 8 (3) : 122 - 122
[24] Hypertensive Treatment in Patients With Metabolic Syndrome
Siegel, David
Swislocki, Arthur L. M.
METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (02) : 95 - 103
[25] TREATMENT OF HYPERTENSION IN PATIENTS WITH THE METABOLIC SYNDROME
Lyoussi, B.
Israili, Z.
JOURNAL OF HYPERTENSION, 2009, 27 : S245 - S245
[26] THE EFFICACY OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS-C
LU, CL
CHAN, CY
HWANG, SJ
LU, RH
LEE, SD
LO, KJ
HEPATOLOGY, 1994, 20 (04) : A372 - A372
[27] Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease
Siano, Maria
De Gregorio, Fabiola
Boggia, Bartolo
Sepe, Angela
Ferri, Pasqualina
Buonpensiero, Paolo
Di Pasqua, Antonio
Raia, Valeria
DIGESTIVE AND LIVER DISEASE, 2010, 42 (06) : 428 - 431
[28] FINAL OUTCOME OF URSODEOXYCHOLIC ACID TREATMENT IN 126 PATIENTS WITH RADIOLUCENT GALLSTONES
GLEESON, D
RUPPIN, DC
SAUNDERS, A
MURPHY, GM
DOWLING, RH
QUARTERLY JOURNAL OF MEDICINE, 1990, 76 (279): : 711 - 729
[29] Combined phlebotomy and ursodeoxycholic acid treatment in the patients with chronic hepatitis C
Wakusawa, S
Ikeda, R
Takikawa, T
Hayashi, H
Yano, M
Yoshioka, K
HEPATOLOGY RESEARCH, 2000, 18 (01) : 54 - 62
[30] Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice
Treeprasertsuk, Sombat
Silachamroon, Udomsak
Krudsood, Srivicha
Huntrup, Arun
Suwannakudt, Plengsakoon
Vannaphan, Suparp
Wilairatana, Polrat
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (02) : 362 - 368

← 1 2 3 4 5 →